Health Trials

Aggressive NK-cell Leukemia

3

Review clinical trials related to Aggressive NK-cell Leukemia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

This is a multicenter, first-in-human, Phase 1/2 study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and anti-tumor activity of DR-01 in adult patients with large granular lymphocytic leukemia or cytotoxic lymphomas

Participants needed: 200
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Dren BioUpdated: Jun 17, 2026Locations: 37
Eligibility criteria

≥18 years of age. [+13]

A reactive LGL lymphocytosis to a viral infection or LGL associated with myelody... [+14]

Read more
Status: Recruiting

A Registry for People With T-cell Lymphoma

The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Researchers will use the information from this database to learn more about how to improve outcomes for people with T-cell lymphoma.

Participants needed: 1,000
Trial details
Biological sex: AllType: ObservationalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: May 20, 2026Locations: 26Duration: 10 Years
Eligibility criteria

Written informed consent [+30]

Patients with of mycosis fungoides, primary cutaneous anaplastic large cell lymp... [+1]

Read more
Status: Recruiting

Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia

This is Phase I/II Dose-Escalation Study to evaluate the tolerability, safety, efficacy and pharmacokinetics of PPMX-T003 in aggressive NK-cell leukemia.

Participants needed: 7
Trial details
Phase: Phase 1, Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Hiroshima University HospitalUpdated: Apr 30, 2025Locations: 1
Eligibility criteria

Patients diagnosed with ANKL (regardless of whether the disease is first or recu...

Patients eligible to receive chemotherapy as treatment for ANKL

Read more